Open AccessAbstract 2167: Efficacy assessment of BTK inhibitor ibrutinib in de novo and viral-induced B cell lymphoma
Author(s) -
Jessie Jingjing Wang,
Meiling Zheng,
Xuesong Huang,
Yumeng Song,
Wubin Qian,
Likun Zhang,
Jie Cai,
Sheng Guo,
Henry Qixiang Li,
Davy Xuesong Ouyang
Publication year - 2018
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2018-2167
Subject(s) - ibrutinib , bruton's tyrosine kinase , mantle cell lymphoma , chronic lymphocytic leukemia , cancer research , lymphoma , b cell receptor , b cell , germinal center , medicine , leukemia , immunology , tyrosine kinase , receptor , antibody